Harvest Fund Management Co., LTD Charles River Laboratories International, Inc. Transaction History

Harvest Fund Management Co., LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $128,777 - $182,503	-504 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $266,697 - $340,548	-759 Reduced 60.1%	504 $189,000
Q2 2021 Aug 11, 2021	BUY	$294.17 - $371.65 $87,662 - $110,751	298 Added 30.88%	1,263 $470,000
Q4 2020 Feb 10, 2021	SELL	$222.0 - $252.62 $82,806 - $94,227	-373 Reduced 27.88%	965 $241,000
Q3 2020 Nov 04, 2020	BUY	$175.56 - $226.45 $124,998 - $161,232	712 Added 113.74%	1,338 $314,000
Q1 2020 May 08, 2020	BUY	$98.9 - $178.34 $54,296 - $97,908	549 Added 712.99%	626 $78,000
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $72,790 - $83,615	-582 Reduced 88.32%	77 $10,000
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $69,254 - $90,434	659 New	659 $75,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.